First Hawaiian Bank Has $2.36 Million Position in Hologic, Inc. (NASDAQ:HOLX)

First Hawaiian Bank increased its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 81.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,133 shares of the medical equipment provider’s stock after purchasing an additional 13,040 shares during the period. First Hawaiian Bank’s holdings in Hologic were worth $2,359,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in HOLX. Macquarie Group Ltd. lifted its position in Hologic by 227.2% during the second quarter. Macquarie Group Ltd. now owns 6,284,053 shares of the medical equipment provider’s stock worth $435,485,000 after purchasing an additional 4,363,687 shares during the period. Wellington Management Group LLP boosted its position in Hologic by 80.0% in the first quarter. Wellington Management Group LLP now owns 8,984,757 shares of the medical equipment provider’s stock valued at $725,070,000 after buying an additional 3,992,822 shares in the last quarter. Norges Bank bought a new position in Hologic in the fourth quarter valued at about $175,900,000. Envestnet Asset Management Inc. increased its position in Hologic by 506.3% in the 1st quarter. Envestnet Asset Management Inc. now owns 1,711,592 shares of the medical equipment provider’s stock valued at $29,345,000 after acquiring an additional 1,429,300 shares during the period. Finally, Ameriprise Financial Inc. grew its position in shares of Hologic by 43.6% in the 1st quarter. Ameriprise Financial Inc. now owns 3,507,667 shares of the medical equipment provider’s stock valued at $283,067,000 after buying an additional 1,065,767 shares during the last quarter. 92.64% of the stock is owned by institutional investors and hedge funds.

Hologic Stock Performance

Hologic stock opened at $72.35 on Friday. The company’s 50-day moving average price is $76.46 and its 200-day moving average price is $79.36. Hologic, Inc. has a twelve month low of $59.78 and a twelve month high of $87.88. The company has a quick ratio of 3.73, a current ratio of 4.42 and a debt-to-equity ratio of 0.54. The company has a market cap of $17.72 billion, a PE ratio of 37.49 and a beta of 1.01.

Hologic (NASDAQ:HOLX) last announced its earnings results on Monday, July 31st. The medical equipment provider reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.04. Hologic had a return on equity of 19.02% and a net margin of 11.99%. The firm had revenue of $984.40 million during the quarter, compared to analysts’ expectations of $960.22 million. During the same quarter in the previous year, the business earned $0.95 EPS. The company’s quarterly revenue was down 1.8% on a year-over-year basis. On average, equities research analysts forecast that Hologic, Inc. will post 3.92 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently weighed in on HOLX shares. Morgan Stanley reissued an “equal weight” rating and issued a $86.00 price objective on shares of Hologic in a research report on Tuesday, August 1st. Citigroup decreased their target price on Hologic from $90.00 to $85.00 and set a “neutral” rating for the company in a research report on Tuesday, August 1st. TheStreet downgraded shares of Hologic from a “b” rating to a “c+” rating in a report on Monday, July 31st. StockNews.com assumed coverage on Hologic in a report on Friday, August 18th. They set a “buy” rating for the company. Finally, Raymond James reduced their price target on shares of Hologic from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 1st. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $88.92.

About Hologic

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.